Dimolegin - PharmaDiall
Alternative Names: 217; Amidine hydrochloride - PharmaDiall; DD-217Latest Information Update: 23 Feb 2022
At a glance
- Originator PharmaDiall
- Class Amides; Anticoagulants; Antithrombotics
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Venous thromboembolism
Most Recent Events
- 12 Jan 2022 Pharmacodynamics data from a preclinical trial in Blood coagulation disorders released by PharmaDiall
- 27 Dec 2021 PharmaDiall completes enrolment in a phase II trial in Venous thromboembolism in Russia (PO) as of December 2021 (NCT05189002)
- 29 Oct 2021 PharmaDiall completes a phase-III trial in Venous thromboembolism in Russia (PO) (NCT05185804)